Comparison of Outcomes and Costs in Patients with Urinary Tract Infections (UTI) or Pneumonia (PNA) with Treatment Initiated in a Physician Office Infusion Center (POIC) versus Those Treated After Hospital Discharge

John S. Adams, MD, FIDSA – Knoxville Infectious Disease Consultants, P.C., Knoxville, TN
Richard C. Prokesch, MD, FIDSA – Infectious Disease Associates, Riverdale GA
Jorge R. Bernett, MD – Infectious Disease Doctors Medical Group, Walnut Creek, CA
Andrew H. Krinsky, MD – Infectious Disease Associates, Sarasota, FL
Robin H. Dretler, MD – Infectious Disease Specialists of Atlanta, Atlanta, GA
Juan Diaz, DO, FACP – Infectious Disease Consultants, Alamonte Springs, FL
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc., Sugar Land, TX

View Poster

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.